DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20173558

Effect of cissus quadrangularis linn and zingiber officinale rosc in osteoarthritis patients

J. Viswanath, Chakrapani Cheekavolu, S. Sankaraiah, Renu Dixit

Abstract


Background: To evaluate the efficacy of Cissus quadrangularis Linn. or Zingiber officinalis Rosc. or in combination treatment of osteoarthritis which reduces joint pain, joint swelling and tenderness without risk of side effects.

Methods: Total 60 patients were selected and divided into 3 groups (each group consist of 20 patients); data were collected before and after treatment of following groups: Group A-Cissus quadrangularis linn-5gm; Group B- Zingiber officinale rosc-5gm; Group C-Treatment of Cissus quadrangularis linn combined with Zingiber officinale rosc-5 gm/dose twice a day with luke warm water.

Results: 60 % cases of joint pain were relieved at the end of the treatment in group B & C, in group A 50%, reduction in joint pain extremely significant in all groups A, B, C (p<0.0001). ‘C’ 80%, ‘A’ 15% and ‘B’5% reduction in symptom of Joint swelling and which is very significant in group A, and group B (p<0.001) and extremely significant in group C (p<0.0001). Symptom of tenderness ‘C’ 90%, ‘A’ 85%, and ‘B’ 10% cases were relived from the complaint. The difference in tenderness is statistically extremely significant when compared between groups (p<0.0001).

Conclusions: Present study reveals that, significant reduction of joint pain, joint swelling and tenderness after treatment of Cissus quadrangularis Linn. or Zingiber officinalis Rosc. and extremely significant reduction of joint swelling and tenderness in combination therapy.


Keywords


Cissus quadrangularis linn, Osteoarthritis, Zingiber officinale rosc

Full Text:

PDF

References


Chopra A, Patil J, Bilampelly V, Relwane J, Tandle HS. Prevalence of rheumatic disease in rural population in western India. A WHO-ILARCOPCORD STUDY. J Assoc Physicians India. 2001;49:240-6.

Chopra A, Patil J, Bilampelly V. The Bhigwan COPCORD: Methodology and first information report, APLAR. J Rheumatol. 1997;1:145-54.

Mahajan A, Jasrotia DS, Manhas AS, Jamwal SS. Prevalence of major rheumatic disorders in Jammu. JK Science. 2003;5:63-6.

Ollier WE, Harrison B and Symmons D. What is the natural history of rheumatoid arthritis, Baillieres Best Pract Res Clin Rheumatol. 2001;15:27-48.

Turek SL. Orthopedics Principles and their Application. 4th edition. Philedelphia: Lippincott Raven; 1998.

Solomon L, Warwick DJ, Nayagam S. Apley’s System of Orthopaedics and Fractures. 8th edition. Great Britain: Hodder Arnold; 2001.

Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of non-steroidal antiinflammatory drugs. N Engl J Med. 1999;340(24):1888-99.

Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, et al. Gastrointestinal toxicity with celecoxib vs non-steroidal antiinflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study. A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA. 2000; 284(10):1247-55.

Vernin G, Parkanyi C. Chemistry of Ginger. In: Babu KN, Ravindran PN. Ginger the Genus Zingiber. Boca Raton: CRC. 2005;469-88.

Thomson M, Al-Qattan KK, Al-Sawan SM, Alnaqeeb MA, Khan I, Ali M. The use of ginger as potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids. 2002;67(6):475-8.

Langner E, Griefenberg S, Greuwald J. Ginger: History and use. Adv Ther. 1998;15(1):25-44.

Lantz RC, Chen GJ, Sarihan M, Solyom AM, Jolad SD, Timmermann BN. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine. 2007;14(2-3):123-8.

Nurtjahja-Tjendraputra E, Ammit AJ, Roufogalis BD, Tran VH, Duke CC. Effective antiplatelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thromb Res. 2003;111(4-5):259-65.

Tjendraputra E, Tran VH, Liu-Brennan D,Roufogalis BD, Duke CC. Effects of Ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg Chem. 2001;29(3):156-63.